Treatment for inclusion body myositis
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of pharmacological and non‐pharmacological treatment for skeletal muscle weakness, atrophy and inflammation in people with IBM. This will:
-
determine whether there is any evidence for the benefit for any treatment; and
-
provide recommendations for future trials in IBM.